This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

On presentation to the health professional with a history of infantile colic

  • exclude any organic cause for the symptoms, e.g. gastro-oesophageal reflux, constipation, infection, etc.
  • the differential includes intestinal obstruction, hernia and febrile illnesses - however there are generally other pointers to these alternative diagnoses

The treatment of this condition is supportive; it usually resolves by about the fourth month of life.

Treatment options include:

  • dietary modifications
    • prevalence of colic is similar between breastfed and bottle-fed infants, hence breastfeeding should not be discontinued

    • hypoallergenic formula preparations for bottle fed infants
      • switching to hydrolysed formulas (from partially hydrolysed to completely hydrolysed formula preparations) have shown to reduce colic symptoms
        • several studies have reported that use of completely hydrolysed formulas resulted in improved clinical symptoms of infantile colic, such as crying time (when cow’s milk formula was used as the comparator)
        • a systematic review stated that benefits reported for hydrolysed formulas were inconsistent (1)

    • soybased formulas are not recommended for infantile colic

    • hypoallergenic maternal diet for breastfed infants
      • a randomized controlled trial reported that breastfed infants of mothers who follow a low-allergen diet, showed significant reduction in colic symptoms (2)
      • any maternal dietary modifications should be accompanied by dietary counseling to ensure adequate nutrition
      • a review states that any maternal diet modification may result in improving symptoms of colic secondary to undiagnosed cows' milk protein allergy in the infant, rather than infantile colic with no underlying cause (3)

  • lactase therapy
    • it was suggested that in a significant number of cases, the immediate cause of infantile colic is transient lactose intolerance, in which cases pretreatment of feeds with lactase can result in considerable symptomatic benefits
    • galactosidase (lactase) drops are mixed with breast or bottle milk feeds up to 24 hours prior to feeding the infant
      • several randomised control trials have reported improvement in symptoms in infants with lactase therapy. This finding is controversial since several other randomised controlled trials noted no improvement with the use of lactase in either breast or formula milk
      • there is inconsistent and conflicting evidence on the benefits of lactase drops for the treatment of infantile colic (3)

  • pharmacological
    • infacol, which contains simethicone (activated dimeticone) - however evidence of benefit is uncertain
    • dicycloverine (dicyclomine), because of its adverse effect profile, is now considered unsafe for use in infants under six months (3,4)

A flowchart for the management of infantile colic has been suggested (6):

 

Notes:

  • probiotics in the management of infantile colic
    • there is some evidence that Lactobacillus reuteri improved colicky symptoms in breastfed infants within 1 week of treatment, compared with simethicone - the authors concluded that probiotics may have a role in the treatment of infantile colic (6)
    • a review stated that there was insufficient evidence to recommend use of probiotics in infantile colic (1)

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.